{"product_id":"glp-3-r-20mg","title":"GLP-3 (R)  20mg","description":"\u003ch2\u003e\u003cstrong\u003eGLP‑3 (R) – 20mg\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eTriple‑Agonist Metabolic Peptide • Lyophilized Powder • Research Use Only\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eDescription:\u003c\/strong\u003e GLP‑3 (R) is an \u003cstrong\u003einvestigational triple‑agonist peptide\u003c\/strong\u003e engineered to activate three major metabolic receptors simultaneously: \u003cstrong\u003eGLP‑1\u003c\/strong\u003e, \u003cstrong\u003eGIP\u003c\/strong\u003e, and \u003cstrong\u003eglucagon\u003c\/strong\u003e. This multi‑pathway engagement produces some of the most profound metabolic effects observed in peptide research, including \u003cstrong\u003esignificant weight reduction\u003c\/strong\u003e, \u003cstrong\u003eenhanced glycemic control\u003c\/strong\u003e, and \u003cstrong\u003eincreased energy expenditure\u003c\/strong\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTriple‑agonist compounds like GLP‑3 (R) have demonstrated metabolic outcomes that surpass single‑ or dual‑agonist analogs, making them a leading focus in advanced obesity and diabetes research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eSpecifications\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003ePeptide:\u003c\/strong\u003e GLP‑3 (R)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eClassification:\u003c\/strong\u003e Triple‑Receptor Agonist (GLP‑1 \/ GIP \/ Glucagon)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eQuantity:\u003c\/strong\u003e 20mg per vial\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003ePurity:\u003c\/strong\u003e \u003cstrong\u003e≥99.8%\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilized powder\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003ePhysical Description:\u003c\/strong\u003e White to off‑white lyophilized powder\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eSolubility:\u003c\/strong\u003e Soluble in aqueous diluents\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eStore at −20°C (−4°F)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eProtect from moisture and prolonged light exposure\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eAfter reconstitution, refrigerate at 2–8°C (36–46°F); use within 30 days\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eGrade:\u003c\/strong\u003e Research Use Only — Not for human consumption, therapeutic, or diagnostic use\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eKey Research Insights\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eUnprecedented Weight Loss\u003c\/strong\u003e GLP‑3 (R) has demonstrated \u003cstrong\u003eaverage weight reductions of up to 24% after 48 weeks\u003c\/strong\u003e in advanced research models—approaching bariatric‑level outcomes.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eTargeted Fat Reduction\u003c\/strong\u003e Studies show significant decreases in \u003cstrong\u003evisceral fat\u003c\/strong\u003e (organ fat) and \u003cstrong\u003esubcutaneous abdominal fat\u003c\/strong\u003e, indicating deep metabolic remodeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eIncreased Calorie Burning\u003c\/strong\u003e The \u003cstrong\u003eglucagon‑agonist component\u003c\/strong\u003e elevates \u003cstrong\u003eenergy expenditure\u003c\/strong\u003e, enhancing natural fat oxidation beyond what GLP‑1 or GIP alone can achieve.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eBlood Sugar \u0026amp; Insulin Control\u003c\/strong\u003e GLP‑3 (R) has been shown to reduce \u003cstrong\u003eHbA1c\u003c\/strong\u003e, improve \u003cstrong\u003einsulin sensitivity\u003c\/strong\u003e, and support remission‑level improvements in \u003cstrong\u003epre‑diabetes\u003c\/strong\u003e and \u003cstrong\u003etype 2 diabetes\u003c\/strong\u003e models.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eCardiometabolic Health\u003c\/strong\u003e Early research indicates improvements in \u003cstrong\u003eblood pressure\u003c\/strong\u003e, \u003cstrong\u003etriglycerides\u003c\/strong\u003e, and \u003cstrong\u003eliver steatosis\u003c\/strong\u003e, suggesting broad systemic benefits.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eMechanistic Interest — How GLP‑3 (R) Works\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eGLP‑3 (R) mimics and amplifies the actions of three endogenous metabolic hormones:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eGLP‑1:\u003c\/strong\u003e Slows gastric emptying and reduces appetite through central satiety pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eGIP:\u003c\/strong\u003e Enhances insulin secretion and improves lipid metabolism.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eGlucagon:\u003c\/strong\u003e Increases energy expenditure and stimulates fat oxidation, driving additional calorie burn.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThis \u003cstrong\u003etriple‑pathway synergy\u003c\/strong\u003e produces metabolic effects far exceeding those of single‑ or dual‑agonist peptides, making GLP‑3 (R) a leading compound in \u003cstrong\u003enext‑generation obesity, diabetes, and cardiometabolic research\u003c\/strong\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eResearch Focus Areas\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eTriple‑agonist metabolic pathway studies\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eBody‑weight reduction and adiposity‑modulation models\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eGlycemic control and HbA1c‑lowering research\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eEnergy‑expenditure and fat‑oxidation mechanisms\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eCardiometabolic health and lipid‑profile investigations\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eObesity, pre‑diabetes, and T2DM research\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Rival Peptides","offers":[{"title":"Default Title","offer_id":48527792439528,"sku":null,"price":299.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0789\/1179\/9528\/files\/Copilot_20260508_202414.png?v=1778290700","url":"https:\/\/rivalpeptides.com\/products\/glp-3-r-20mg","provider":"Rival Peptides","version":"1.0","type":"link"}